Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

March 22, 2016March 22, 2016

Tennessee Passes Asbestos Anti-Fraud Bill to Stop ‘Double Dipping’ in Legal Claims

News

The Tennessee state legislature has passed a bill intending to stop lawyers representing people in asbestos lawsuits from “double dipping,” or filing multiple claims with asbestos bankruptcy trusts to receive multiple payouts ... Read more

March 17, 2016March 18, 2016

New Mesothelioma Drug, HXR9, Seen to Induce Cell Death in Tumors for a First Time

News

Researchers confirmed in a new study that HOX genes are potential therapeutic targets for the treatment of mesothelioma, and demonstrated that a new drug, HXR9, successfully halted tumor growth and induced apoptosis ... Read more

March 9, 2016March 9, 2016

Pleural Mesothelioma Genomic Analysis Finds Some 2,700 Functional Mutation in Tumors

News

In a new comprehensive genomic study, researchers identified thousands of recurrent and protein-altering mutations in 216 malignant pleural mesothelioma (MPM) tumors. The analysis was performed using MedGenome’s OncoMD mutation database, ... Read more

March 3, 2016March 3, 2016

Malignant Pleural Mesothelioma Study Finds Genetic Alterations in Tumors, Some with Possibility of Treatment

News

Researchers involved in the International Mesothelioma Program at Brigham and Women’s Hospital (BWH), working with scientists at Genentech, analyzed hundreds of malignant pleural mesothelioma tumors and, through genomic analyses, found a ... Read more

February 24, 2016February 26, 2016

Some Mesothelioma Cases of Unknown Origin Found to Point to Asbestos Exposure

News

Researchers at the University of Milan re-evaluated hundreds of malignant mesothelioma (MM) cases that had been deemed “asbestos exposure unknown” in light of new knowledge regarding possible sources of asbestos. The team linked previously ... Read more

February 23, 2016February 23, 2016

Mesothelioma Applied Research Foundation to Award Grants to 5 New Research Projects

News

The Mesothelioma Applied Research Foundation, a non-profit organization dedicated to finding a cure for mesothelioma and providing support for patients and families, announced that five research projects were the recipients ... Read more

January 18, 2016January 18, 2016

Mesothelioma Patients Being Recruited for Phase 1b Trial for FP-1039

News

Five Prime Therapeutics, Inc., a biotechnology company focused on novel protein therapeutics for the treatment of cancer and inflammatory diseases, provided an update to the ongoing Phase 1b clinical trial, conducted ... Read more

January 12, 2016January 12, 2016

Malignant Pleural Mesothelioma Study Reveals Increase in Metastasis-Associated Gene

News

In a new study, researchers revealed that the metastasis-associated gene 1 (MTA1) is “upregulated,” or increased as a result of another variable, in malignant pleural mesothelioma (MPM), and that it ... Read more

January 6, 2016

Malignant Mesothelioma Cells Respond to Combination Therapy in Lab

News

In a new study, researchers showed both in vivo and in vitro that a combination therapy of a chemotherapeutic drug and an IL-1R antagonist could be a beneficial treatment strategy for ... Read more

January 4, 2016January 6, 2016

Calretinin Found to Affect Proliferation and Mobility Rates of Mouse Mesothelial Cells

News

In a new study, researchers at the University of Fribourg and University Hospital Zürich have demonstrated calretinin’s possible role in mesothelial cells’ mobility and proliferation as well as in the development ... Read more